Reconstruction of Photoreceptor Outer Layers after Steroid Therapy in Solar Retinopathy

Nakamura, Masaki; Komatsu, Koji; Katagiri, Satoshi; Hayashi, Takaaki; Nakano, Tadashi

doi:10.1155/2018/7850467

Cited by 5 publications

(4 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fluorescein angiography was normal in all cases (100%) in this study, this agreed with the case reported by Nakamura [17] in opposite to Ault Jain study as fluorescein angiography identified classic window defects in 19 eyes (10 of 11 patients) [15].…”

Section: Discussionsupporting

confidence: 92%

Solar maculopathy: prognosis over one year follow up

et al. 2019

View full text Add to dashboard Cite

Background To document the visual acuity, spectral domain optical coherence tomography (SD-OCT) findings and prognosis in10 eyes of 6 patients with foveal damage from solar retinopathy in 1 year. Methods This was a prospective, observational case series of patients presented by solar maculopathy at Ophthalmology department, Sohag University. All patients underwent visual acuity (VA) testing, refraction, dilated fundus examination fluorescein angiography (FA) and SD-OCT (spectral Domain ocular coherence Tomography) imaging and follow up for 1 year. Results The mean age was 16.5 years (range 9–27 years, both eyes are affected in 4 patients. The mean spherical equivalent (SE) was – 0.25 ± 0.50 D. The visual acuity of the affected eyes ranged from 0.4 to 0.9 on presentation. At presentation Significant foveal pathology was identified on SD-OCT in 10 eyes, All eyes showed disruption of the photoreceptor ellipsoid zone and the interdigitation zone on SD-OCT, Follow up of the cases continued for 1 year.100% of cases showed improvement in VA: 20% eyes regained 1, 50% eyes with VA of 0.9; two eyes 20% 0.8 and one eyes (10%) with 0.4. The improvement began after 1 week and reached its maximum and became stationary after the 6th month of follow up, the outer retinal hole persist in OCT in 80% of cases. Conclusion Solar maculopathy has a good prognosis yet shows no improvement after 6 months. Young age might pose as a risk factor.

show abstract

Section: Discussionsupporting

confidence: 92%

Solar maculopathy: prognosis over one year follow up

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Nakamura et al . reported the improvement of anatomical and functional outcomes after systemic prednisolone and posterior sub-tenon triamcinolone in more severe eye presentation, which suggested the role of steroids in suppressing inflammatory reaction shortening the clinical course in subacute solar retinopathy cases [ 9 ].…”

Section: Discussionmentioning

confidence: 99%

Managing solar retinopathy with suprachoroidal triamcinolone acetonide injection in a young girl: a case report

Marashi¹,

Baba

Zazo

2021

J Med Case Reports

View full text Add to dashboard Cite

Background Solar retinopathy is a disease that causes photochemical toxicity in the retinal fovea tissues, leading to an acute decrease of vision. Case presentation This case report is an interventional case of an asymptomatic 17-year-old Caucasian female with a history of suddenly decreased vision due to solar retinopathy. The patient was managed with a custom-made needle injection of triamcinolone acetonide in the suprachoroidal space. Four months post suprachoroidal injection showed an anatomical and functional improvement in the ellipsoid zone layer through optical coherence tomography signal reappearance. In addition, the best-corrected visual acuity had improved from 0.1 to 1.0 on the Snellen chart with the disappearance of the scotoma. However, there was a mild increase in intraocular pressure after this procedure, controlled with topical hypertensive eye drops. Conclusion Suprachoroidal triamcinolone acetonide injection using a custom-made needle showed both functional and anatomical improvement of macular changes post-solar retinopathy, with acceptable safety outcomes in a young female.

show abstract

“…For this purpose, authors have reported administering steroids, usually systemically in HHL-induced maculopathy, systemically and locally in solar retinopathy, or topically in unilateral cases. 5 , 6 , 7 , 8 , 13 , 14 Here we present a patient who received early sub-Tenon triamcinolone acetonide injection for HHL-induced maculopathy.…”

Section: Introductionmentioning

confidence: 99%

Sub-Tenon Triamcinolone Acetonide Injection in the Acute Treatment of Handheld Laser-Induced Maculopathy

Cankurtaran¹,

Gediz²

2022

tjo

View full text Add to dashboard Cite

Handheld laser (HHL)-induced maculopathy has increased in frequency in recent years and can lead to severe retinal damage and vision loss. Although there is no consensus on the treatment of HHL-induced maculopathy, the use of systemic steroids to limit damage to the retina has been discussed. In this article, we present a patient who underwent early sub-Tenon triamcinolone acetonide injection for HHL-induced maculopathy. To our knowledge, sub-Tenon steroid administration has not been previously reported in the treatment of HHL-induced retinopathy.

show abstract

Reconstruction of Photoreceptor Outer Layers after Steroid Therapy in Solar Retinopathy

Cited by 5 publications

References 9 publications

Solar maculopathy: prognosis over one year follow up

Solar maculopathy: prognosis over one year follow up

Managing solar retinopathy with suprachoroidal triamcinolone acetonide injection in a young girl: a case report

Sub-Tenon Triamcinolone Acetonide Injection in the Acute Treatment of Handheld Laser-Induced Maculopathy

Contact Info

Product

Resources

About